BENDAMUSTINE, BORTEZOMIB AND DEXAMETHASONE (BVD) IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA : THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM) 2009-01 PROTOCOL

被引：0
|
作者：
Rodon, P. [1 ]
Hulin, C. [2 ]
Pegourie, B. [2 ]
Tiab, M. [3 ]
Anglaret, B. [3 ]
Benboubker, L. [2 ]
Jardel, H. [3 ]
Decaux, O. [2 ]
Kolb, B. [2 ]
Roussel, M. [2 ]
Garderet, L. [4 ]
Leleu, X. [5 ]
Royer, B. [2 ]
Banos, A. [3 ]
Benramdane, R. [3 ]
Cony-Makhoul, P. [3 ]
Dib, M. [2 ]
Fontan, J. [2 ]
Stoppa, A. [6 ]
Traulle, C. [7 ]
Vilque, J. [8 ]
Moreau, P. [2 ]
Mathiot, C. [9 ]
Avet-Loiseau, H. [2 ]
机构：
[1] Ctr Hosp, Blois, France
[2] CHU, Nancy, France
[3] CH, La Roche Sur Yon, France
[4] Hop St Antoine, Paris, France
[5] CHRU, Lille, France
[6] Inst Paoli Calmettes, Marseille, France
[7] Hop Sud, Lyon, France
[8] Ctr Francois Baclesse, Caen, France
[9] Inst Curie, Paris, France
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0835
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [1] Bendamustine, bortezomib, and dexamethasone (BVD) in elderly patients with relapsed/refractory multiple myeloma (RRMM): The Intergroupe Francophone du Myelome (IFM) 2009-01 protocol.
    Rodon, Philippe
    Hulin, Cyrille
    Pegourie, Brigitte
    Tiab, Mourad
    Anglaret, Bruno
    Benboubker, Lotfi
    Jardel, Henry
    Decaux, Olivier
    Kolb, Brigitte
    Roussel, Murielle
    Garderet, Laurent
    Leleu, Xavier
    Fitoussi, Olivier
    Chaleteix, Carine
    Casassus, Philippe
    Lenain, Pascal
    Moreau, Philippe
    Petillon, Marie-Odile
    Mathiot, Claire
    Avet-Loiseau, Herve
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Bendamustine, Bortezomib and Dexamethasone (BVD) in Elderly Patients with Multiple Myeloma in First Relapse: Updated Results of the Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
    Rodon, Philippe
    Hulin, Cyrille
    Pegourie, Brigitte
    Tiab, Mourad
    Anglaret, Bruno
    Benboubker, Lotfi
    Jardel, Henry
    Decaux, Olivier
    Kolb, Brigitte
    Roussel, Murielle
    Garderet, Laurent
    Leleu, Xavier
    Fitoussi, Olivier
    Chaleteix, Carine
    Casassus, Philippe
    Lenain, Pascal
    Moreau, Philippe
    Petillon, Marie Odile
    Mathiot, Claire
    Avet-Loiseau, Herve
    BLOOD, 2012, 120 (21)
  • [3] Bendamustine, Bortezomib and Dexamethasone (BVD) In Elderly Patients With Multiple Myeloma In First Relapse: Final Analysis Of The Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
    Rodon, Philippe
    Hulin, Cyrille
    Pegourie, Brigitte
    Tiab, Mourad
    Anglaret, Bruno
    Benboubker, Lotfi
    Jardel, Henry
    Decaux, Olivier
    Kolb, Brigitte
    Roussel, Murielle
    Garderet, Laurent
    Leleu, Xavier
    Fitoussi, Olivier
    Chaleteix, Carine
    Casassus, Philippe
    Lenain, Pascal
    Royer, Bruno
    Banos, Anne
    Benramdane, Riad
    Cony-Makhoul, Pascale
    Dib, Mamoun
    Fontan, Jean
    Stoppa, Anne-Marie
    Traulle, Catherine
    Vilque, Jean-Pierre
    Petillon, Marie-Odile
    Mathiot, Claire
    Avet-Loiseau, Herve
    Moreau, Philippe
    BLOOD, 2013, 122 (21)
  • [4] Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial
    Rodon, Philippe
    Hulin, Cyrille
    Pegourie, Brigitte
    Tiab, Mourad
    Anglaret, Bruno
    Benboubker, Lotfi
    Jardel, Henry
    Decaux, Olivier
    Kolb, Brigitte
    Roussel, Murielle
    Garderet, Laurent
    Leleu, Xavier
    Fitoussi, Olivier
    Chaleteix, Carine
    Casassus, Philippe
    Lenain, Pascal
    Royer, Bruno
    Banos, Anne
    Benramdane, Riad
    Cony-Makhoul, Pascale
    Dib, Mamoun
    Fontan, Jean
    Stoppa, Anne-Marie
    Traulle, Catherine
    Vilque, Jean-Pierre
    Petillon, Marie-Odile
    Mathiot, Claire
    Dejoie, Thomas
    Avet-Loiseau, Herve
    Moreau, Philippe
    HAEMATOLOGICA, 2015, 100 (02) : E56 - E59
  • [5] SEVERE INFECTION IN ELDERLY PATIENTS TREATED WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF THE INTER-GROUPE FRANCOPHONE DU MYELOME (IFM) 2009 01 PROTOCOL
    Rodon, P.
    Pegourie, B.
    Garderet, L.
    Casassus, P.
    Decaux, O.
    Roussel, M.
    Chaleteix, C.
    Royer, B.
    Tiab, M.
    Leleu, X.
    Mathiot, C.
    Hulin, C.
    Moreau, P.
    Lortholary, O.
    Fermand, J. -P.
    HAEMATOLOGICA, 2015, 100 : 501 - 502
  • [6] ENHANCED ACTIVITY OF POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED REFRACTORY MYELOMA IRRESPECTIVE TO EFFICACY IN THEIR LAST PRIOR LINE OF THERAPY. ON BEHALF OF IFM (INTERGROUPE FRANCOPHONE DU MYELOME).
    Leleu, X. L.
    Roussel, M.
    Arnulf, B.
    Moreau, P.
    Traulle, C.
    Marit, G.
    Mathiot, C.
    Petillon, M.
    Macro, M.
    Pegourie, B.
    Kolb, B.
    Stoppa, A.
    Brechignac, S.
    Garderet, L.
    Royer, B.
    Hulin, C.
    Benboubker, L.
    Decaux, O.
    Escoffre-Barbe, M.
    Michallet, M.
    Caillot, D.
    Fermand, J. P.
    Avet-Loisea, H.
    Attal, M.
    Facon, T.
    HAEMATOLOGICA, 2012, 97 : 113 - 113
  • [7] Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myelome 2009-02
    Leleu, Xavier
    Attal, Michel
    Arnulf, Bertrand
    Moreau, Philippe
    Traulle, Catherine
    Marit, Gerald
    Mathiot, Claire
    Petillon, Marie Odile
    Macro, Margaret
    Roussel, Murielle
    Pegourie, Brigitte
    Kolb, Brigitte
    Stoppa, Anne Marie
    Hennache, Bernadette
    Brechignac, Sabine
    Meuleman, Nathalie
    Thielemans, Beatrice
    Garderet, Laurent
    Royer, Bruno
    Hulin, Cyrille
    Benboubker, Lotfi
    Decaux, Olivier
    Escoffre-Barbe, Martine
    Michallet, Mauricette
    Caillot, Denis
    Fermand, Jean Paul
    Avet-Loiseau, Herve
    Facon, Thierry
    BLOOD, 2013, 121 (11) : 1968 - 1975
  • [8] BENDAMUSTINE, BORTEZOMIB AND DEXAMETHASONE (BVD) IN ELDERLY MM PROGRESSIVE AFTER 1ST LINE THERAPY (IFM 2009-01 TRIAL): PREDICTIVE FACTORS OF DEFAVOURABLE OUTCOME
    Rodon, P.
    Hulin, C.
    Pegourie, B.
    Tiab, M.
    Anglaret, B.
    Benboubker, L.
    Jardel, H.
    Decaux, O.
    Kolb, B.
    Roussel, M.
    Garderet, L.
    Leleu, X.
    Fitoussi, O.
    Chaleteix, C.
    Casassus, P.
    Lenain, P.
    Royer, B.
    Banos, A.
    Benramdane, R.
    Cony-Makhoul, P.
    Dib, M.
    Fontan, J.
    Stoppa, A.
    Traulle, C.
    Vilque, J.
    Petillon, M.
    Mathiot, C.
    Moreau, P.
    Avet-Loiseau, H.
    HAEMATOLOGICA, 2013, 98 : 100 - 100
  • [9] Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myeloma
    Fenk, Roland
    Michael, Mark
    Zohren, Fabian
    Graef, Thorsten
    Czibere, Akos
    Bruns, Ingmar
    Neumann, Frank
    Fenk, Barbara
    Haas, Rainer
    Kobbe, Guido
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2345 - 2351
  • [10] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Nappi, D.
    Basile, S.
    Marano, L.
    Peluso, I
    Simeone, L.
    Vitagliano, O.
    Romano, A.
    Palmieri, S.
    Rocco, S.
    Pane, F.
    Ferrara, F.
    HAEMATOLOGICA, 2018, 103 : 38 - 38
12345